Korro Bio (KRRO)
NASDAQ:KRRO
US Market
Holding KRRO?
Track your performance easily

Korro Bio (KRRO) Financial Statements

406 Followers

Korro Bio Financial Overview

Korro Bio's market cap is currently ―. The company's EPS TTM is $-25.487; its P/E ratio is -2.28; Korro Bio is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-2.43. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ -1.77M$ 580.00K$ 593.00K
Gross Profit--$ -1.77M$ 580.00K$ 593.00K
EBIT$ -21.80M$ -19.54M$ -39.50M$ -11.62M$ -10.79M
EBITDA$ -21.07M$ -18.81M$ -37.83M$ -11.24M$ -10.30M
Net Income Common Stockholders$ -21.83M$ -19.56M$ -39.22M$ -11.61M$ -10.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 157.43M$ 138.80M$ 166.15M$ 41.72M$ 46.48M
Total Assets$ 249.59M$ 197.99M$ 221.66M$ 46.35M$ 79.38M
Total Debt$ 38.46M$ 35.92M$ 33.21M$ 1.43M$ 27.81M
Net Debt$ -118.97M$ -102.89M$ -132.94M$ -40.30M$ -18.67M
Total Liabilities$ 51.51M$ 46.63M$ 51.75M$ 9.61M$ 33.98M
Stockholders Equity$ 198.08M$ 151.36M$ 169.91M$ 36.74M$ 45.41M
Cash Flow-
Free Cash Flow$ -20.55M$ -27.50M$ -47.66M$ -4.80M$ -8.42M
Operating Cash Flow$ -14.59M$ -21.89M$ -39.92M$ -4.80M$ -8.42M
Investing Cash Flow$ -102.39M$ -5.61M$ -20.36M$ 6.82M$ 19.21M
Financing Cash Flow$ 67.56M$ 139.00K$ 201.89M$ 2.00K$ -11.67M
Currency in USD

Korro Bio Earnings and Revenue History

Korro Bio Debt to Assets

Korro Bio Cash Flow

Korro Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis